• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌和卵巢癌的诊断年龄与多原发性癌症

Age at diagnosis and multiple primary cancers of the breast and ovary.

作者信息

Suris-Swartz P J, Schildkraut J M, Vine M F, Hertz-Picciotto I

机构信息

Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, USA.

出版信息

Breast Cancer Res Treat. 1996;41(1):21-9. doi: 10.1007/BF01807033.

DOI:10.1007/BF01807033
PMID:8932873
Abstract

This nested case-control study assessed the relationship between a woman's age at the time of her initial primary breast or ovarian cancer diagnosis and the risk of a second primary cancer at the other of these two sites. Multiple primary breast and ovarian cancer cases whose initial breast or ovarian diagnosis occurred in 1970-1989 and a random sample of single primary breast or ovarian cancer controls diagnosed in the same years were identified through tumor registries at Duke University Medical Center and the University of North Carolina. Women diagnosed with an initial primary breast cancer at age < or = 50 years were 4.3 times (95% CI: 1.8-10.6) more likely to have developed a subsequent ovarian cancer compared to those diagnosed after age 50. A relationship between an early age at diagnosis (< or = 50) of ovarian cancer and subsequent diagnosis of breast cancer was not found (odds ratio (OR) = 0.6; 95% CI: 0.2-2.0). Adjustment for stage at diagnosis, treatment, year of diagnosis and length of follow-up using Cox Proportional Hazards modeling techniques supported these relationships, yielding a hazard ratio (HR) for the development of a second primary cancer at the alternate site of 4.6 (95% CI: 1.8-11.5) for women with an initial breast cancer diagnosis and 0.6 (95% CI: 0.2-2.2) for women with an initial ovarian cancer diagnosis. Multiple primary breast and ovarian cancer patients diagnosed with an initial breast cancer at or prior to age 50 may represent a distinct subgroup of women with a germline mutation that confers susceptibility to both breast and ovarian cancers.

摘要

这项巢式病例对照研究评估了女性初次诊断原发性乳腺癌或卵巢癌时的年龄与这两个部位中另一个部位发生第二原发性癌症风险之间的关系。通过杜克大学医学中心和北卡罗来纳大学的肿瘤登记处,确定了1970 - 1989年首次诊断为乳腺癌或卵巢癌的多原发性乳腺癌和卵巢癌病例,以及同年诊断为单原发性乳腺癌或卵巢癌的对照的随机样本。与50岁以后诊断的女性相比,初次诊断原发性乳腺癌时年龄≤50岁的女性发生后续卵巢癌的可能性高4.3倍(95%置信区间:1.8 - 10.6)。未发现卵巢癌早期诊断(≤50岁)与后续乳腺癌诊断之间存在关联(优势比(OR)= 0.6;95%置信区间:0.2 - 2.0)。使用Cox比例风险建模技术对诊断分期、治疗、诊断年份和随访时间进行调整后,支持了这些关系,初次诊断为乳腺癌的女性在另一个部位发生第二原发性癌症的风险比(HR)为4.6(95%置信区间:1.8 - 11.5),初次诊断为卵巢癌的女性为0.6(95%置信区间:0.2 - 2.2)。初次诊断为乳腺癌且年龄在50岁及以前的多原发性乳腺癌和卵巢癌患者可能代表了一个具有种系突变的独特女性亚组,该突变使她们易患乳腺癌和卵巢癌。

相似文献

1
Age at diagnosis and multiple primary cancers of the breast and ovary.乳腺癌和卵巢癌的诊断年龄与多原发性癌症
Breast Cancer Res Treat. 1996;41(1):21-9. doi: 10.1007/BF01807033.
2
The genetic epidemiology of second primary breast cancer.第二原发性乳腺癌的遗传流行病学
Am J Epidemiol. 1992 Oct 15;136(8):937-48. doi: 10.1093/oxfordjournals.aje.a116566.
3
Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.基于人群的他莫昔芬治疗与后续卵巢癌、子宫内膜癌和乳腺癌的研究。
J Natl Cancer Inst. 1995 Sep 20;87(18):1359-64. doi: 10.1093/jnci/87.18.1359.
4
Italian cancer figures, report 2013: Multiple tumours.《2013年意大利癌症数据报告:多发性肿瘤》
Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152.
5
Breast cancer risk factors and second primary malignancies among women with breast cancer.乳腺癌女性患者的乳腺癌风险因素及第二原发性恶性肿瘤
Breast Cancer Res Treat. 2007 Oct;105(2):195-207. doi: 10.1007/s10549-006-9446-y. Epub 2006 Dec 21.
6
Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.X染色体失活偏倚与乳腺癌和卵巢癌状态:BRCA1的X连锁修饰因子的证据
J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. doi: 10.1093/jnci/djn345. Epub 2008 Oct 28.
7
Reduced risk of breast, endometrial and ovarian cancer in women with celiac disease.乳癌、子宫内膜癌和卵巢癌风险降低:乳糜泻女性的福音
Int J Cancer. 2012 Aug 1;131(3):E244-50. doi: 10.1002/ijc.26454. Epub 2011 Dec 14.
8
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
9
Multiple primary cancers of the breast, endometrium and ovary.
Eur J Cancer Clin Oncol. 1989 Dec;25(12):1927-32. doi: 10.1016/0277-5379(89)90374-x.
10
Risk of Endometriosis and Subsequent Ovary and Breast Cancers in Nurses: A Population-Based Cohort Study in Taiwan.护士的子宫内膜异位症及后续卵巢癌和乳腺癌风险:来自台湾的基于人群的队列研究。
Int J Environ Res Public Health. 2019 Sep 18;16(18):3469. doi: 10.3390/ijerph16183469.

引用本文的文献

1
Risk of second primary cancer among breast cancer patients: A systematic review and meta-analysis.乳腺癌患者发生第二原发性癌症的风险:一项系统评价和荟萃分析。
Front Oncol. 2023 Jan 17;12:1094136. doi: 10.3389/fonc.2022.1094136. eCollection 2022.
2
The ectopic expression of BRCA1 is associated with genesis, progression, and prognosis of breast cancer in young patients.BRCA1 的异位表达与年轻患者乳腺癌的发生、发展和预后相关。
Diagn Pathol. 2012 Dec 31;7:181. doi: 10.1186/1746-1596-7-181.

本文引用的文献

1
Inherited breast and ovarian cancer. What are the risks? What are the choices?遗传性乳腺癌和卵巢癌。风险有哪些?有哪些选择?
JAMA. 1993 Apr 21;269(15):1975-80.
2
Epidemiology of breast cancer. Findings from the nurses' health study.
Cancer. 1993 Feb 15;71(4 Suppl):1480-9. doi: 10.1002/cncr.2820710413.
3
A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers.
Cancer. 1993 Jan 15;71(2 Suppl):589-93. doi: 10.1002/cncr.2820710215.
4
Genetic epidemiology of epithelial ovarian cancer.
Cancer. 1993 Jan 15;71(2 Suppl):566-72. doi: 10.1002/cncr.2820710212.
5
Personal characteristics relating to risk of invasive epithelial ovarian cancer in older women in the United States.
Cancer. 1993 Jan 15;71(2 Suppl):558-65. doi: 10.1002/cncr.2820710211.
6
Age contrast in ovarian pathology.
Cancer. 1993 Jan 15;71(2 Suppl):537-44. doi: 10.1002/cncr.2820710208.
7
Assessment of relative risk of second primary tumors after ovarian cancer and of the usefulness of double primary cases as a source of material for genetic studies with a cancer registry.
Cancer. 1993 Aug 1;72(3):819-27. doi: 10.1002/1097-0142(19930801)72:3<819::aid-cncr2820720330>3.0.co;2-u.
8
Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer.BRCA1的分子克隆:一种早发性家族性乳腺癌和卵巢癌相关基因。
Breast Cancer Res Treat. 1993 Nov;28(2):121-35. doi: 10.1007/BF00666425.
9
The calculation of breast cancer risk for women with a first degree family history of ovarian cancer.
Breast Cancer Res Treat. 1993 Nov;28(2):115-20. doi: 10.1007/BF00666424.
10
Loss of heterozygosity on chromosome 17q11-21 in cancers of women who have both breast and ovarian cancer.同时患有乳腺癌和卵巢癌的女性癌症患者17号染色体q11 - 21区域杂合性缺失。
Am J Obstet Gynecol. 1995 Mar;172(3):908-13. doi: 10.1016/0002-9378(95)90020-9.